Last update:

Weight management news

Meal timing in time-restricted eating matters for metabolic health, find study

Time-restricted eating has emerged as a popular dietary approach because it focuses on when people eat rather than strictly limiting calories. Instead of counting calories, individuals restrict their daily food intake to ...

You've reached your weight loss goal on GLP-1 medications. What now?

GLP-1 drugs have ushered in a new era in weight loss.

Your gut remembers every diet

The summer holidays are often a time of excess. Rich food, larger portions and more frequent social eating are part of the season. Once it's over, many people feel the urge to compensate. Brief flits with juice cleanses, ...

ADHD and methylphenidate tied to higher adult BMI

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and methylphenidate exposure with higher adult overweight/obesity and slightly shorter adult height at ages 20 ...

Two days of oatmeal can reduce cholesterol level

A short-term oat-based diet appears to be surprisingly effective at reducing the cholesterol level. This is indicated by a trial by the University of Bonn, which has now been published in Nature Communications. The participants ...

Molecule: What's in this dangerous, illegal slimming pill?

It's the kind of promise that stops thumbs mid-scroll: "Take Molecule and forget food exists." Viral TikTok clips show influencers flaunting rapid weight-loss transformations, tapping into the body image concerns that leave ...

Gut bacterium could be key to tackling obesity crisis

The internet, libraries and bookshops are full of plans and advice on how to lose weight, from fad diets to intense exercise routines. But there could be another route to keeping the pounds away, and that's with a gut bacterium ...

GLP-1 and health: Beyond weight loss in the Ozempic era

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people ...